Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-19-000257

Options or other derivatives

  • Pres. Diagnostics & Genom acquired 30,272 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kelderman Kim · Pres. Diagnostics & Genom

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2019-08-07 Grant or award : show line 1 in the form Restricted Stock Units +2,363 2,363 D
2019-08-07 Grant or award : show line 2 in the form Stock Options (Right to Buy) +11,961 11,961 D
2019-08-07 Grant or award : show line 3 in the form Stock Options (Right to Buy) +15,948 15,948 D
Loading xslF345X03/edgar.xml…